Skip to content
The Policy VaultThe Policy Vault

SunosiMedical Mutual

Excessive Daytime Sleepiness associated with Narcolepsy

Initial criteria

  • Patient age ≥ 18 years
  • Patient has been evaluated using polysomnography and multiple sleep latency test (MSLT)
  • Diagnosis of narcolepsy has been confirmed, according to the prescriber
  • Sunosi is prescribed by or in consultation with a sleep disorder specialist, psychiatrist, or neurologist
  • Patient has tried ONE of the following: central nervous system (CNS) stimulant, generic modafinil, or generic armodafinil

Reauthorization criteria

  • Response to therapy is required for continuation of therapy

Approval duration

1 year